[ad_1] Reviewed by Emily Henderson, B.Sc.November 16, 2020 The fish oil-based drug known as omega-3 carboxylic acids or omega-3 CAs did not decrease the risk of cardiac events compared to a placebo, according to recent research presented today at the American Heart Association’s 2020 scientific sessions. The meeting will be …
Read More »No secondary prevention benefits with Omega-3 in the elderly
[ad_1] Omega-3 fatty acids in addition to standard care did not reduce major cardiovascular events or death in elderly survivors of acute myocardial infarction (MI) in the OMEMI randomized trial. In addition to the lack of benefit observed at 2 years, there was a non-significant increase in new onset atrial …
Read More »